High-flow nasal cannula therapy in a predominantly African American population with COVID-19 associated acute respiratory failure.
Paul L NguyenHeba OsmanDonovan WatzaSuman KhicherAditi SharmaGreg DysonGhulam SaydainAyman SoubaniPublished in: BMJ open respiratory research (2021)
In a population disproportionately affected by COVID-19, we present key indicators of likely HFNC failure and highlight a patient population in which aggressive monitoring and intervention are warranted.
Keyphrases
- respiratory failure
- african american
- coronavirus disease
- extracorporeal membrane oxygenation
- sars cov
- mechanical ventilation
- randomized controlled trial
- stem cells
- liver failure
- acute respiratory distress syndrome
- case report
- respiratory syndrome coronavirus
- positive airway pressure
- hepatitis b virus
- sleep apnea
- chronic rhinosinusitis